Regeneron Pharmaceuticals, Inc. (REGN)
945.63
-12.13
(-1.27%)
USD |
NASDAQ |
Nov 18, 16:00
950.88
+5.25
(+0.56%)
After-Hours: 19:44
Regeneron Pharmaceuticals Total Return Level : 966.64 for Nov. 17, 2026
Total Return Level Chart
Historical Total Return Level Data
| Date | Value |
|---|---|
| November 17, 2026 | 966.64 |
| November 16, 2026 | 961.23 |
| November 13, 2026 | 964.33 |
| November 12, 2026 | 960.01 |
| November 11, 2026 | 968.31 |
| November 10, 2026 | 924.55 |
| November 09, 2026 | 928.49 |
| November 06, 2026 | 912.74 |
| November 05, 2026 | 911.27 |
| November 04, 2026 | 939.30 |
| November 03, 2026 | 982.39 |
| November 02, 2026 | 970.17 |
| October 30, 2026 | 936.49 |
| October 29, 2026 | 826.36 |
| October 28, 2026 | 820.81 |
| October 27, 2026 | 823.67 |
| October 26, 2026 | 815.16 |
| October 23, 2026 | 812.48 |
| October 22, 2026 | 826.68 |
| October 21, 2026 | 813.14 |
| October 20, 2026 | 814.97 |
| October 19, 2026 | 789.29 |
| October 16, 2026 | 798.07 |
| October 15, 2026 | 803.72 |
| October 14, 2026 | 785.58 |
| Date | Value |
|---|---|
| October 13, 2026 | 760.10 |
| October 12, 2026 | 769.88 |
| October 09, 2026 | 753.46 |
| October 08, 2026 | 746.43 |
| October 07, 2026 | 749.00 |
| October 06, 2026 | 745.57 |
| October 05, 2026 | 733.21 |
| October 02, 2026 | 742.02 |
| October 01, 2026 | 741.62 |
| September 30, 2026 | 765.30 |
| September 29, 2026 | 757.47 |
| September 28, 2026 | 759.22 |
| September 25, 2026 | 795.35 |
| September 24, 2026 | 803.40 |
| September 23, 2026 | 809.25 |
| September 22, 2026 | 811.35 |
| September 21, 2026 | 805.57 |
| September 18, 2026 | 792.13 |
| September 17, 2026 | 796.77 |
| September 16, 2026 | 781.79 |
| September 15, 2026 | 781.29 |
| September 14, 2026 | 801.10 |
| September 11, 2026 | 788.74 |
| September 10, 2026 | 800.62 |
| September 09, 2026 | 815.14 |
Total Return Level Definition
The total return level allows investors to view the performance of a security inclusive of both price appreciation and dividends/distributions. Total return level is seen as the most accurate calculation that produces returns consistent with most other sources.
Total Return Level Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Return Level Benchmarks
| Gilead Sciences, Inc. | 249.53 |
| AbbVie, Inc. | 507.46 |
| Vertex Pharmaceuticals, Inc. | 534.20 |
| Amgen, Inc. | 685.72 |
| Alnylam Pharmaceuticals, Inc. | 156.50 |